STNT MEDICAL COUNCIL OF CANADA NEWZZZ// Stevia Nutra

New Post Public Reply Private Reply Replies (0) Message Board
Compensated Post
shakerzzz

STNT >> MEDICAL COUNCIL OF CANADA NEWZZZ// Stevia Nutra Appoints Head of Prestigious Medical Council to Board of Directors

2013-03-18 09:00 ET - News Release



CORNER BROOK, Newfoundland -- (Business Wire)

Stevia Nutra Corporation (OTC:QB STNT) – (The Company), an Agro-Management company focused on stevia agronomics, is pleased to announce the appointment of Dr. Ian Bowmer, Executive Director of the Medical Council of Canada (MCC), to the Company’s Board of Directors.

Dr. Bowmer graduated from McGill University’s medical program in 1969 and went on to do his residency in internal medicine and infectious diseases at Royal Victoria Hospital and McGill University. He served as Dean of Medicine at Memorial University in Newfoundland and Labrador, Canada from 1996 to 2003 and was appointed Executive Director of the Medical Council of Canada in 2007. Dr. Bowmer has garnered an abundance of policy development and governance experience within the Canadian medical community and is the recipient of several prominent awards for his work in medical education.

“Following the recent decision by Health Canada approving the use of steviol glycosides in a wide range of food and beverage products, we are pleased to welcome Dr. Ian Bowmer to our team,” says Company President Brian Dicks. “Dr. Bowmer’s leadership within the MCC and his knowledge and endorsement of the health benefits of stevia will bolster our on-going policy efforts to support stevia use in Canada and other jurisdictions. With his support we look forward to moving our advocacy agenda forward and warmly welcome Ian to our board.”

The recipient of several prestigious awards for his vision and contributions to medical education, Dr. Bowmer is one of the 13 non-governmental expert representatives on the Medical Council and Chair of the Working Committee.

“I am very excited to join the Company’s Board of Directors at a time where there is increasing recognition of the health benefits of stevia over traditional sugars and chemical sweeteners,” says Dr. Bowmer. “I look forward to engaging with government and private sector entities about the potential of stevia as a food and beverage ingredient, and the health benefits it offers to consumers, especially those battling diabetes and other obesity related illnesses.”

About Us

Stevia Nutra:

Stevia Nutra is an Agro-Management company focused on stevia agronomics which includes plant breeding, proprietary agricultural practices and post-harvest techniques. Stevia Nutra intends to invest heavily in R&D and IP acquisition and manage large-scale plantations for the production of high value stevia products.

Stevia Nutra is dedicated to utilizing best agronomic and business practices to demonstrate the sustainability and profitability of stevia production. By subscribing to, and implementing the performance standards published by the World Bank, Stevia Nutra is committed to becoming the premier producer of the highest quality stevia. Stevia Nutra recognizes the potential this remarkable plant has to reduce the global epidemic of obesity and diabetes and promote general good health. The Company's priority will be to embrace sustainability, innovation to promote profitable growth.

Stevia and the stevia sector

Stevia is the world’s only all natural zero calorie sweetener. Since being approved by the United States Food and Drug Administration late in 2008, and the EU in late 2011, stevia can now be found in over 6,000 food, beverage and medicine products, with many more new products to follow as global consumers are making healthier food choices.

Stevia is the fastest growing sweetener product in the world. The World Health Organization estimates that stevia will replace up to 20% of the global sweetener market valued at over $USD 10 Billion. Zenith International expects that stevia agriculture production will have to triple within two years to keep up with the strong demand. Only one year after FDA approval in the U.S., stevia sales surged past both aspartame and saccharin in the tabletop sugar market.

Safe Harbor Statement

Some statements in this news release contain forward-looking information or forward-looking statements for the purposes of applicable securities laws.These statements include, but are not limited to, statements with respect to the ability of the Company to become the world’s largest producer of the highest quality stevia, the ability of Ecologica to provide opportunities to the Company to engage in relationship with its sister companies and the ability of Ecologica to rapidly and effectively accelerate operations on the ground and avoid unnecessary cost-consuming overhead.These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements.Such factors include, among others, the timing and completion of contemplated financings, the actual use of proceeds, receipt of regulatory approvals and the ability to secure sufficient land for cultivation.In making the forward-looking statements, the Company has applied several material assumptions including, but not limited to, the assumptions that: (1) the proposed corporate development and expansion plans will proceed as planned; (2) market fundamentals will result in sustained commodities pricing and (3) any additional financing needed will be available on reasonable terms.The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise except as otherwise required by applicable securities legislation. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, market acceptance of our products and services; operational difficulties relating to international operations; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the food sector, and our ability to attract and retain qualified personnel. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements.

Further information on the Company can be found at www.sec.gov and the company’s website at www.stevianutra.com.


Contacts:

Stevia Nutra Corporation
Brad Long, 1-888-960-STNT (7868)
Investor Relations
investor@stevianutra.com

Source: Stevia Nutra Corporation

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading